Articles scientifiques

Adult onset asynchronous multifocal eosinophilic granuloma of bone: an 11-year follow-up.

Auteurs : Dallaudière B, Kerger J, Malghem J, Galant C, Lecouvet FE
Année : 2015
Journal : Acta Radiol Open
Volume : 4(2)
Pages : 2047981614552217

Principles Governing A-to-I RNA Editing in the Breast Cancer Transcriptome.

Auteurs : Fumagalli D, Gacquer D, Rothé F, Lefort A, Libert F, Brown D, Kheddoumi N, Shlien A, Konopka T, Salgado R, Larsimont D, Polyak K, Willard-Gallo K, Desmedt C, Piccart-Gebhart M, Abramowicz M, Campbell PJ, Sotiriou C, Detours V
Année : 2015
Journal : Cell Rep
Volume : 13
Pages : 277-89

Evolving paradigms in multifocal breast cancer.

Auteurs : Salgado R, Aftimos P, Sotiriou C, Desmedt C
Année : 2015
Journal : Semin. Cancer Biol.
Volume : 31C
Pages : 111-118

Erratum to: Efficacy of eribulin in women with metastatic breast cancer: a pooled analysis of two phase 3 studies.

Auteurs : Twelves C, Cortes J, Vahdat L, Olivo M, He Y, Kaufman PA, Awada A
Année : 2015
Journal : Breast Cancer Res. Treat.
Volume : 149(1)
Pages : 313

Radioembolisation and portal vein embolization before resection of large hepatocellular carcinoma.

Auteurs : Bouazza F, Poncelet A, Garcia CA, Delatte P, Engelholm JL, Gomez Galdon M, Deleporte A, Hendlisz A, Vanderlinden B, Flamen P, Donckier V
Année : 2015
Journal : World J Gastroenterol
Volume : 21
Pages : 9666-70

Adjuvant systemic therapy in breast cancer: quo vadis?

Auteurs : Sonnenblick A, Piccart-Gebhart M
Année : 2015
Journal : Ann Oncol
Volume : 26(8)
Pages : 1629-34

Benefit to neoadjuvant anti-human epidermal growth factor receptor 2 (HER2)-targeted therapies in HER2-positive primary breast cancer is independent of phosphatase and tensin homolog deleted from chromosome 10 (PTEN) status.

Auteurs : Nuciforo PG, Aura C, Holmes E, Prudkin L, Jimenez J, Martinez P, Ameels H, de la Peña L, Ellis C, Eidtmann H, Piccart-Gebhart M, Scaltriti M, Baselga J
Année : 2015
Journal : Ann Oncol
Volume : 26
Pages : 1494-500

Pregnancy after breast cancer: Are young patients willing to participate in clinical studies?

Auteurs : Pagani O, Ruggeri M, Manunta S, Saunders C, Peccatori F, Cardoso F, Kaufman B, Paluch-Shimon S, Gewefel H, Gallerani E, Abulkhair O, Pistilli B, Warner E, Saloustros E, Perey L, Zaman K, Rabaglio M, Gelber S, Gelber Rd, Godhirsch A, Korde L, Azim HA, Partridge AH
Année : 2015
Journal : Breast
Volume : 24(3)
Pages : 201-7

Cardiac assessment of early breast cancer patients 18years after treatment with cyclophosphamide-, methotrexate-, fluorouracil- or epirubicin-based chemotherapy.

Auteurs : de Azambuja E, Ameye L, Diaz M, Vandenbossche S, Aftimos P, Hernández SB, Shih-Li C, Delhaye F, Focan C, Cornez N, Vindevoghel A, Beauduin M, Lemort M, Paesmans M, Suter T, Piccart-Gebhart M
Année : 2015
Journal : Eur J Cancer
Volume : 51
Pages : 2517-24

Tumour infiltrating lymphocytes (TILs) in breast cancer during pregnancy.

Auteurs : Azim HA, Vingiani A, Peccatori F, Viale G, Loi S, Pruneri G
Année : 2015
Journal : Breast
Volume : 24(3)
Pages : 290-3

Severe bilateral panuveitis during melanoma treatment by Dabrafenib and Trametinib.

Auteurs : Draganova D, Kerger J, Caspers L, Willermain F
Année : 2015
Journal : J Ophthalmic Inflamm Infect
Volume : 5
Pages : 17

High HER2 expression correlates with response to the combination of lapatinib and trastuzumab.

Auteurs : Scaltriti M, Nuciforo P, Bradbury I, Sperinde J, Agbor-Tarh D, Campbell C, Chenna A, Winslow J, Serra V, Parra JL, Prudkin L, Jimenez J, Aura C, Harbeck N, Pusztai L, Ellis C, Eidtmann H, Arribas J, Cortes J, de Azambuja E, Piccart-Gebhart M, Baselga J
Année : 2015
Journal : Clin Cancer Res
Volume : 21(3)
Pages : 569-76

A phase I pharmacokinetics study of lapatinib and tamoxifen in metastatic breast cancer (EORTC 10053 Lapatam study).

Auteurs : Fumoleau P, Koch KM, Brain E, Lokiec F, Rezai K, Awada A, Hayward L, Werutsky G, Bogaerts J, Marréaud S, Cardoso F
Année : 2014
Journal : Breast
Volume : 23(5)
Pages : 663-9

A rare case of prostatic extra gonadal germ cell tumor in a young adult: Review of the literature

Auteurs : Sideris S, Aftimos P, Georgala A, Sirtaine N, Awada A, Gil T
Année : 2014
Journal : J Clin Diagn Res
Volume : 2
Pages : 2

Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial.

Auteurs : Bonnefoi H, Litière S, Piccart-Gebhart M, Macgrogan G, Fumoleau P, Brain E, Petit T, Rouanet P, Jassem J, Moldovan C, Bodmer A, Zaman K, Cufer T, Campone M, Luporsi E, Malmström P, Werutsky G, Bogaerts J, Bergh J, Cameron DA
Année : 2014
Journal : Ann Oncol
Volume : 25(6)
Pages : 1128-36

The Role of Age on Dose Limiting Toxicities (DLTs) in Phase I Dose-escalation Trials.

Auteurs : Schwandt A, Harris PJ, Hunsberger S, Deleporte A, Smith GL, Vulih D, Anderson BD, Ivy SP
Année : 2014
Journal : Clin Cancer Res
Volume : 20(18)
Pages : 4768-75

Prospective non-interventional multicentre observational trial of first-line anti-cancer treatment in patients with metastatic renal cell cancer in Belgium.

Auteurs : Cornelis N, Vermassen T, Schallier D, Machiels JP, Gil T, Debruyne PR, DHondt R, Bols A, Schrijvers D, Mebis J, Lumen N, Rottey S
Année : 2014
Journal : Acta Clin Belg
Volume : 69(5)
Pages : 335-40

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis.

Auteurs : Cortazar P, Zhang L, Untch M, Mehta K, Costantino JP, Wolmark N, Bonnefoi H, Cameron D, Gianni L, Valagussa P, Swain SM, Prowell T, Loibl S, Wickerham DL, Bogaerts J, Baselga J, Perou C, Blumenthal G, Blohmer J, Mamounas EP, Bergh J, Semiglazov V, Justice R, Eidtmann H, Paik S, Piccart-Gebhart M, Sridhara R, Fasching PA, Slaets L, Tang S, Gerber B, Geyer CE, Pazdur R, Ditsch N, Rastogi P, Eiermann W, Von Minckwitz G
Année : 2014
Journal : Lancet
Volume : 384(9938)
Pages : 164-72

Treatment options for pregnant women with ovarian tumors.

Auteurs : Mancari R, Tomasi-Cont N, Sarno MA, Azim HA, Franchi D, Carinelli S, Biglia N, Colombo N, Peccatori FA
Année : 2014
Journal : Int J Gynecol Cancer
Volume : 24(6)
Pages : 967-72

Delivering precision medicine in oncology today and in future-the promise and challenges of personalised cancer medicine: a position paper by the European Society for Medical Oncology (ESMO).

Auteurs : Ciardiello F, Arnold D, Casali PG, Cervantes A, Douillard JY, Eggermont A, Eniu A, McGregor K, Peters S, Piccart-Gebhart M, Popescu R, van Cutsem E, Zielinski C, Stahel R
Année : 2014
Journal : Ann Oncol
Volume : 25(9)
Pages : 1673-8